• Explore /
  • Poster
  • / Prostate oncologic therapy while ensuring neurovascular conservation (POTEN-C): A phase II randomized controlled trial of stereotactic ablative body radiotherapy (SAbR) with or without neurovascular sparing for erectile function preservation in localized prostate cancer.

Prostate oncologic therapy while ensuring neurovascular conservation (POTEN-C): A phase II randomized controlled trial of stereotactic ablative body radiotherapy (SAbR) with or without neurovascular sparing for erectile function preservation in localized prostate cancer.

Abstract Poster

Authors

Neil Desai

Neil Bipinchandra Desai

UT Southwestern, Dallas, TX

Neil Bipinchandra Desai , Michael Ryan Folkert , Andrew Leiker , Yulong Yan , Daniel N. Costa , Robert Timothy Dess , Daniel Eidelberg Spratt , Aurelie Garant , Raquibul Hannan , Robert D. Timmerman

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Quality of Care/Quality Improvement

Clinical Trial Registration Number

03525262

Citation

J Clin Oncol 38, 2020 (suppl 6; abstr TPS381)

Abstract #

TPS381

Poster Bd #

Q1

Abstract Disclosures

Similar Posters

First Author: Jonathan W. Lischalk

First Author: Jonathan David Tward

First Author: Bridget F. Koontz

First Author: Deepika Reddy